QUANTUM X LABS INC. quarterly report, Q2 FY2019

Filing summary

Issuer identification: The filing is for Viewbix Inc. (formerly Virtual Crypto Technologies, Inc.), not “QUANTUM X LABS INC.” The supplied company metadata does not match the filing.

Business context and reporting period

This unaudited Form 10-Q covers the quarter and six months ended June 30, 2019. During the period, the company was developing software and hardware for cryptocurrency transactions. On July 25, 2019, after quarter-end, it completed an exchange to acquire Algomizer’s 99.83% interest in Viewbix Israel, whose business includes a video engagement platform. The company subsequently changed its name to Viewbix Inc. and its OTCQB symbol to VBIX.

Financial performance and liquidity

MetricThree months ended June 30, 2019Six months ended June 30, 2019Comparable 2018 period
Revenue$0$0$0
Research and development$16,039$25,452$266,954 and $630,965, respectively
General and administrative$249,303$440,513$356,515 and $1,420,798, respectively
Total operating expenses$265,342$465,965$623,469 and $2,051,763, respectively
Net loss$269,172$353,830$3,239,229 and $24,041,605, respectively
Basic and diluted loss per share$0.04$0.05$0.77 and $6.93, respectively

Operating margins are not meaningful because the company reported no revenue. The substantially lower comparative-period losses primarily reflect unusually large 2018 finance expenses related to changes in convertible-note terms; six-month finance income was $112,135 in 2019 versus finance expense of $21,989,842 in 2018.

  • At June 30, 2019, cash and cash equivalents were $233,299, total current assets were $252,243, and current liabilities were $1,089,146. Working capital was negative $836,903, compared with negative $416,476 at December 31, 2018.
  • Current liabilities included $503,217 of short-term convertible notes, $10,556 of accrued interest, and $469,525 of liabilities held for sale. The notes bore 1% annual interest, were convertible at $0.15 per share, and were due through January 1, 2020. The filing says they were converted into 3,434,889 shares after quarter-end.
  • Six-month operating cash outflow was $281,497; investing cash inflow was reported as $14,877 in the cash-flow statement; financing cash flow was $0. Cash declined from $499,919 at year-end 2018 to $233,299.
  • Total liabilities were $1,089,146, exceeding total assets of $252,243. The filing reports no revenue and states that additional capital is needed.

Material changes, outlook, and risks

  • The July 25, 2019 acquisition/share exchange materially changed the company’s business focus. In connection with closing, the company issued 20,281,085 shares to Algomizer and 3,434,889 shares to noteholders, and issued Algomizer 7,298,636 warrants with exercise prices of $0.48 and $0.80. The company reported 31,201,669 common shares outstanding on August 13, 2019.
  • Management said the company expects to fund needs through equity or convertible debt, debt financing, or strategic arrangements, but has no committed external funding source and gave no specific financial guidance. It warned that financing may be unavailable or dilutive and that operations could be delayed, reduced, or terminated if capital cannot be raised.
  • The company stated that accumulated losses and negative operating cash flows raise substantial doubt about its ability to continue as a going concern.
  • Reported R&D expense fell substantially year over year; management attributed the quarterly reduction to downsizing and slower cryptocurrency-product development. The six-month MD&A narrative says R&D expense “increased,” although the financial statements show a decrease from $630,965 to $25,452.
  • After quarter-end, Viewbix Israel was named in a lawsuit by three shareholders alleging entitlement to preferred shares or alternative compensation related to the transaction. The filing also describes legacy claims by a former employee and former employees of Emerald Israel; management disputes or expects dismissal of the claims and reports the former employees’ claimed amounts were under $96,000.
  • Management concluded disclosure controls were effective as of June 30, 2019, but the filing’s wording also refers to “certain material weaknesses,” making the basis for that conclusion unclear.

Important facts for investors to verify

  • Confirm the issuer identity: the filing identifies Viewbix Inc., while the request metadata names Quantum X Labs Inc.
  • Review the completed acquisition terms, post-quarter share and warrant issuances, resulting dilution, and the reported August 13 share count.
  • Assess near-term liquidity, going-concern uncertainty, and the company’s ability to obtain additional financing.
  • Reconcile the R&D expense discussion with the reported figures and the investing cash inflow, which is $14,877 in the cash-flow statement but $14,607 in MD&A.
  • Monitor the post-quarter shareholder litigation and legacy Emerald Israel proceedings, and clarify the disclosure-controls statement regarding material weaknesses.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.